Directed new share issue in Nel ASA (NO) — NOK 1.3 billion Industrials Directed new share issue in Nel ASA (NO) — NOK 1.3 billion
Sale of Wexus Group AS (NO) to Algeco Group (UK) — Amount not disclosed Real Estate Sale of Wexus Group AS (NO) to Algeco Group (UK) — Amount not disclosed
Directed new share issue in Scatec Solar ASA (NO) — NOK 2.0 billion Cleantech, Renewables & Infrastructure Directed new share issue in Scatec Solar ASA (NO) — NOK 2.0 billion
Directed new share issue in Colosseum Man Holding AS (NO) — NOK 100 million Healthcare Directed new share issue in Colosseum Man Holding AS (NO) — NOK 100 million
Initial public offering of Pexip Holding ASA (NO) on Oslo Stock Exchange – NOK 2.4 billion TMT Initial public offering of Pexip Holding ASA (NO) on Oslo Stock Exchange – NOK 2.4 billion
Directed new share issue in BerGenBio´s ASA (NO) — NOK 500 million Healthcare Directed new share issue in BerGenBio´s ASA (NO) — NOK 500 million
Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million Business Services Directed new share issue in Nordic Aquafarms AS (NO) – NOK 88 million
Private placement in Cloudberry Clean Energy AS (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 158 million Cleantech, Renewables & Infrastructure Private placement in Cloudberry Clean Energy AS (NO) and subsequent admittance for trading on Euronext Growth Oslo – NOK 158 million
Acquisition of a portfolio of 43 public use properties and financing in Mälardalens Omsorgsfastigheter Holding AB (publ) – Underlying property value of SEK 842 million Real Estate Acquisition of a portfolio of 43 public use properties and financing in Mälardalens Omsorgsfastigheter Holding AB (publ) – Underlying property value of SEK 842 million
Sale of Phonect AS (NO) to Unifon AS (NO) — Amount not disclosed TMT Sale of Phonect AS (NO) to Unifon AS (NO) — Amount not disclosed
Senior secured bond issue by Hurtigruten Group AS (NO) — EUR 300 million Transportation & Shipping Senior secured bond issue by Hurtigruten Group AS (NO) — EUR 300 million
Directed new share issue in BerGenBio´s ASA (NO) — NOK 220 million Healthcare Directed new share issue in BerGenBio´s ASA (NO) — NOK 220 million